Pfizer, Ranbaxy win dismissal of antitrust lawsuit over generic Lipitor
Pfizer, Ranbaxy won dismissal of an antitrust lawsuit accusing them of conspiring to delay sales of generic versions of the cholesterol drug Lipitor. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - September 12, 2014 Category: Pharmaceuticals Source Type: news

South Carolina Litigation Adds 200 Lipitor Lawsuits in a Month, as...
The Firm is evaluating potential Lipitor lawsuits on behalf of individuals who allegedly developed Lipitor diabetes injuries after taking the cholesterol-lowering statin drug.(PRWeb September 01, 2014)Read the full story at http://www.prweb.com/releases/lipitor-lawsuit/lipitor-diabetes/prweb12132739.htm (Source: PRWeb: Medical Pharmaceuticals)
Source: PRWeb: Medical Pharmaceuticals - September 1, 2014 Category: Pharmaceuticals Source Type: news

Lipitor Lawsuit News: Bernstein Liebhard LLP Notes Growing Number of...
The Firm is evaluating Lipitor lawsuits on behalf of individuals who allegedly developed Type 2 diabetes due to their use of the cholesterol-lowering statin.(PRWeb August 12, 2014)Read the full story at http://www.prweb.com/releases/lipitor-lawsuit/lipitor-diabetes/prweb12089424.htm (Source: PRWeb: Medical Pharmaceuticals)
Source: PRWeb: Medical Pharmaceuticals - August 13, 2014 Category: Pharmaceuticals Source Type: news

Lipitor Lawsuits Among Women Soar in Past 5 Months (FREE)
By Amy Orciari Herman Edited by Susan Sadoughi, MD, and André Sofair, MD, MPH Lawsuits by U.S. women who blame Lipitor (atorvastatin) for their type 2 diabetes have soared over … (Source: Physician's First Watch current issue)
Source: Physician's First Watch current issue - August 11, 2014 Category: Primary Care Source Type: news

Pfizer Confronts Surge of Lawsuits Over LipitorPfizer Confronts Surge of Lawsuits Over Lipitor
Pharmaceutical giant Pfizer is facing a mounting wave of lawsuits by women who allege that the company knew about possible serious side effects of its blockbuster anti-cholesterol drug Lipitor but never properly warned the public. Reuters Health Information (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - August 8, 2014 Category: Consumer Health News Tags: Diabetes & Endocrinology News Source Type: news

Pfizer confronts surge of lawsuits over Lipitor
(Reuters) - Pharmaceutical giant Pfizer is facing a mounting wave of lawsuits by women who allege that the company knew about possible serious side effects of its blockbuster anti-cholesterol drug Lipitor but never properly warned the public. (Source: Reuters: Health)
Source: Reuters: Health - August 8, 2014 Category: Consumer Health News Tags: healthNews Source Type: news

Atorvastatin protects against cerebral ischemia/reperfusion injury
(Neural Regeneration Research) In addition to its lipid-lowering effect, statins exert anti-inflammatory and antioxidant effects as well. Statins also provide protection against renal, pulmonary and myocardial ischemia/reperfusion injury. However, little evidence is available on similar changes in cerebral ischemia/reperfusion injury. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - August 4, 2014 Category: Global & Universal Source Type: news

NICE Lowers Risk Threshold for Starting StatinsNICE Lowers Risk Threshold for Starting Statins
The new guidelines are an update to the 2006 clinical recommendations and push for a more aggressive approach to patient management. Physicians should start treatment with atorvastatin in patients with a 10-year risk of cardiovascular disease that exceeds 10%. Heartwire (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - July 18, 2014 Category: Consumer Health News Tags: Cardiology News Source Type: news

'More adults should be taking statins,' says NICE
Conclusion Despite somewhat hysterical media coverage to the contrary ("millions more to be given statins," according to the Daily Express), nobody will be forced to take statins. If your GP does recommend statins, you should ask them to explain the benefits and risks for you personally of starting statin treatment. You may want to find out more about statins before making up your mind – the NHS Choices Health A-Z information on statins is a good place to start. If you do experience troublesome side effects while taking statins, contact your GP or the doctor in charge of your care. It could be the case that a...
Source: NHS News Feed - July 18, 2014 Category: Consumer Health News Tags: Heart/lungs Medication QA articles Source Type: news

Prices of 108 diabetes, cardiac formulations fixed: NPPA
The drugs that will become cheaper would include atorvastatin, gliclazide, glimepiride, heparin and metolazone among others. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - July 14, 2014 Category: Pharmaceuticals Source Type: news

Pharma’s statin fightback – or dilemma?
Are generic statins getting in the way of pharma’s plans? (Source: Alliance for Natural Health)
Source: Alliance for Natural Health - May 21, 2014 Category: Complementary Medicine Authors: Sophie Tags: Aseem Malhotra Astra Zeneca atorvastatin BMJ Catalyst: Heart Of The Matter cholesterol Cholesterol Treatment Trialists CTT Dr Malcolm Kendrick europe Health Insight UK international Jerome Burne John Abramson Lipitor NICE P Source Type: news

The Bell Law Firm Renews Investigations into Lipitor Injury Claims as...
The Charleston-based law firm continues to investigate claims of women who developed Type II diabetes after taking the cholesterol-lowering drug Lipitor as 56 cases are centralized into multidistrict...(PRWeb April 30, 2014)Read the full story at http://www.prweb.com/releases/bell-law-investigates/lipitor-injury-claims/prweb11811430.htm (Source: PRWeb: Medical Pharmaceuticals)
Source: PRWeb: Medical Pharmaceuticals - May 1, 2014 Category: Pharmaceuticals Source Type: news

US Food and Drug Administration okays safety of Indian medicines
The US drug regulator says it has detected no impurity in the Indian version of cholesterol-lowering generic drug Atorvastatin in recent tests. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - March 27, 2014 Category: Pharmaceuticals Source Type: news

Lipitor MDL Approved for Type 2 Diabetes Litigation: McSweeney /...
Federal litigation involving Pfizer's cholesterol-lowering drug Lipitor has been consolidated before a single judge in South Carolina.(PRWeb March 25, 2014)Read the full story at http://www.prweb.com/releases/2014/03/prweb11664980.htm (Source: PRWeb: Medical Pharmaceuticals)
Source: PRWeb: Medical Pharmaceuticals - March 26, 2014 Category: Pharmaceuticals Source Type: news